Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers.
Journal: European journal of pain (London, England)
Published: December 10, 2025
Oliceridine for postoperative pain and opioid-related complications: The intravenous oliceridine and opioid-related complications (VOLITION) prospective cohort study.
Journal: Journal of clinical anesthesia
Published: April 07, 2025
A Multisite, 6-Month, Open-Label Study of Maintenance Transcranial Magnetic Stimulation for Adolescents with Treatment-Resistant Depression.
Journal: Journal of child and adolescent psychopharmacology
Published: December 24, 2024
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects.
Journal: Clinical pharmacology and therapeutics
Published: July 01, 2024
Neurocognitive Effect of Biased µ-Opioid Receptor Agonist Oliceridine, a Utility Function Analysis and Comparison with Morphine.
Journal: Anesthesiology
Published: September 01, 2023
Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with Morphine.
Journal: Anesthesiology
Published: December 20, 2022
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 07, 2022
Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk.
Journal: Heart rhythm
Published: July 19, 2021
Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain.
Journal: Journal of comparative effectiveness research
Published: July 09, 2021
Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation.
Journal: The international journal of neuropsychopharmacology
Published: July 08, 2021
Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.
Journal: Pain and therapy
Published: June 04, 2021
Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.
Journal: Pain and therapy
Published: November 04, 2020
Last Updated: 09/26/2026